Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
Clinical trial NCT00052624 · UNKNOWN
Trial details
- NCT number
- NCT00052624
- Sponsor
- Xenova Biomedix
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.